Previous studies have shown the presence of circulating cPC by NGF in blood of a high percentage of SMM and MM, and to a less extent also MGUS cases [51–54], which could be used at diagnosis for a more comprehensive management of these patients, as regards the timing to perform a BM study. This evidence concerns the gene NGF and Miyoshi myopathy.